These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mechanisms of intestinal epithelial cell injury and colitis in interleukin 2 (IL2)-deficient mice. Baumgart DC; Olivier WA; Reya T; Peritt D; Rombeau JL; Carding SR Cell Immunol; 1998 Jul; 187(1):52-66. PubMed ID: 9682004 [TBL] [Abstract][Full Text] [Related]
5. The lymphatic system controls intestinal inflammation and inflammation-associated Colon Cancer through the chemokine decoy receptor D6. Vetrano S; Borroni EM; Sarukhan A; Savino B; Bonecchi R; Correale C; Arena V; Fantini M; Roncalli M; Malesci A; Mantovani A; Locati M; Danese S Gut; 2010 Feb; 59(2):197-206. PubMed ID: 19846409 [TBL] [Abstract][Full Text] [Related]
6. Epithelial dysfunction associated with the development of colitis in conventionally housed mdr1a-/- mice. Resta-Lenert S; Smitham J; Barrett KE Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G153-62. PubMed ID: 15774938 [TBL] [Abstract][Full Text] [Related]
7. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: central role of epithelial-derived MMP. Castaneda FE; Walia B; Vijay-Kumar M; Patel NR; Roser S; Kolachala VL; Rojas M; Wang L; Oprea G; Garg P; Gewirtz AT; Roman J; Merlin D; Sitaraman SV Gastroenterology; 2005 Dec; 129(6):1991-2008. PubMed ID: 16344067 [TBL] [Abstract][Full Text] [Related]
8. Regulation and expression of multidrug resistance (MDR) transcripts in the intestinal epithelium. Li M; Hurren R; Zastawny RL; Ling V; Buick RN Br J Cancer; 1999 Jun; 80(8):1123-31. PubMed ID: 10376961 [TBL] [Abstract][Full Text] [Related]
9. TGF-beta1 gene transfer to the mouse colon leads to intestinal fibrosis. Vallance BA; Gunawan MI; Hewlett B; Bercik P; Van Kampen C; Galeazzi F; Sime PJ; Gauldie J; Collins SM Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G116-28. PubMed ID: 15778431 [TBL] [Abstract][Full Text] [Related]
10. Development and validation of a novel IL-10 deficient cell transfer model for colitis. Ikenoue Y; Tagami T; Murata M Int Immunopharmacol; 2005 Jun; 5(6):993-1006. PubMed ID: 15829415 [TBL] [Abstract][Full Text] [Related]
11. Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Khalil PN; Weiler V; Nelson PJ; Khalil MN; Moosmann S; Mutschler WE; Siebeck M; Huss R Gastroenterology; 2007 Mar; 132(3):944-54. PubMed ID: 17383423 [TBL] [Abstract][Full Text] [Related]
12. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice. Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212 [TBL] [Abstract][Full Text] [Related]
13. A primary dysregulation in the immunoregulatory role of the intestinal mucosal epithelial cell in inflammatory bowel disease pathogenesis? Biology of inflammatory response as tissue pattern entities in Crohn's versus ulcerative colitis. Agius LM J Theor Biol; 2004 Mar; 227(2):219-28. PubMed ID: 14990386 [TBL] [Abstract][Full Text] [Related]
14. Colitis-related public T cells are selected in the colonic lamina propria of IL-10-deficient mice. Takahashi I; Matsuda J; Gapin L; DeWinter H; Kai Y; Tamagawa H; Kronenberg M; Kiyono H Clin Immunol; 2002 Mar; 102(3):237-48. PubMed ID: 11890710 [TBL] [Abstract][Full Text] [Related]
15. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis. Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961 [TBL] [Abstract][Full Text] [Related]
16. Biodegradable microspheres targeting mucosal immune-regulating cells: new approach for treatment of inflammatory bowel disease. Nakase H; Okazaki K; Tabata Y; Chiba T J Gastroenterol; 2003 Mar; 38 Suppl 15():59-62. PubMed ID: 12698874 [TBL] [Abstract][Full Text] [Related]
17. A role for proteinase-activated receptor-1 in inflammatory bowel diseases. Vergnolle N; Cellars L; Mencarelli A; Rizzo G; Swaminathan S; Beck P; Steinhoff M; Andrade-Gordon P; Bunnett NW; Hollenberg MD; Wallace JL; Cirino G; Fiorucci S J Clin Invest; 2004 Nov; 114(10):1444-56. PubMed ID: 15545995 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic potency of IL2-caspase 3 targeted treatment in a murine experimental model of inflammatory bowel disease. Shteingart S; Rapoport M; Grodzovski I; Sabag O; Lichtenstein M; Eavri R; Lorberboum-Galski H Gut; 2009 Jun; 58(6):790-8. PubMed ID: 18978179 [TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Fukata M; Michelsen KS; Eri R; Thomas LS; Hu B; Lukasek K; Nast CC; Lechago J; Xu R; Naiki Y; Soliman A; Arditi M; Abreu MT Am J Physiol Gastrointest Liver Physiol; 2005 May; 288(5):G1055-65. PubMed ID: 15826931 [TBL] [Abstract][Full Text] [Related]
20. Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression. Fantini MC; Rizzo A; Fina D; Caruso R; Sarra M; Stolfi C; Becker C; Macdonald TT; Pallone F; Neurath MF; Monteleone G Gastroenterology; 2009 Apr; 136(4):1308-16, e1-3. PubMed ID: 19192480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]